Litcius/Paper detail

Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy

Yu-Te Huang, Peng‐Tai Tien, Po‐Yu Chen, Chi-Lan Yang, San‐Ni Chen

2024Graefe s Archive for Clinical and Experimental Ophthalmology10 citationsDOI

Topics & Concepts

AfliberceptMedicineSerous fluidOphthalmologyPro re nataRetrospective cohort studyVisual acuityRetinalSurgeryInternal medicineChemotherapyRanibizumabBevacizumabRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Development and Disorders
Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy | Litcius